HDAC inhibitor Santacruzamate A, Purity ≥98%

Cat. No.: X23-10-ZQ322

HDAC inhibitor Santacruzamate A, Purity ≥98%

Synonym: 1477949-42-0; Santacruzamate A; CAY10683; Santacruzamate A (CAY10683); CAY10683 (SantacruzaMate A); Ethyl N-[4-oxo-4-(2-phenylethylamino)butyl]carbamate; HDAC inhibitor

  • MDL: MFCD28348356
  • CAS Number: 1477949-42-0
  • Compound CID: 72946782
Product Size
25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Santacruzamate A, soluble in DMSO and ethanol and insoluble in water, induces DNA damage and the inhibition of DNA repair processes. It targets HDAC2, HDAC4, and HDAC6.
Molecular Weight
278.35
Molecular Formula
C15H22N2O3
Targets
HDAC2: 119 pM; HDAC4: >1000 nM; HDAC6: 434 pM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 47 mg/mL (168.85 mM); Water: Insoluble; Ethanol: 47 mg/mL (168.85 mM)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Santacruzamate A is used to study its selective inhibition of HDAC2, relevant to neurodegenerative and cancer research.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.